Huh, 65,149 patient N-acetylcysteine prophylaxis study: 26% fewer cases [p<0.0001] https://c19p.org/huhna
copied to clipboard
Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea
et al., medRxiv, doi:10.1101/2020.05.04.20089904 (Preprint)
Retrospective database analysis of 65,149 in South Korea, showing significantly lower cases with existing N-acetylcysteine treatment. The journal version of this paper does not present the N-acetylcysteine results.
|
risk of case, 26.2% lower, RR 0.74, p < 0.001, treatment 710 of 13,788 (5.1%), control 4,462 of 51,361 (8.7%), adjusted per study, odds ratio converted to relative risk, multivariable.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Huh et al., 5/4/2020, retrospective, database analysis, South Korea, Asia, preprint, 10 authors.
Contact:
eastside1st@gmail.com.
huh
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.